TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CLYM

Climb Bio Inc

Healthcare · Biotechnology

12.50$ -11.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Climb Bio Inc (CLYM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 246 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CLYM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
113 110 109 226 222 217 201 192 182 168 152 246
112 110 109 226 198 155 100 87 91 106 113 187
57 93 105 223 146 87 29 23 26 36 8.4 44
107 107 105 223 193 151 98 85 87 101 110 183
1.9 2.5 2.0 – 1.0 1.1 1.4 – – – – –
3.0 2.9 3.0 3.7 3.4 5.3 7.4 6.6 5.3 7.3 4.3 6.7
2.9 2.8 3.0 3.7 3.4 4.9 7.0 6.2 4.9 7.0 4.1 5.9
0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.5
0.7 0.1 0.1 0.5 0.3 0.7 0.8 0.9 0.5 2.3 0.9 1.1
110 108 106 222 219 212 193 186 177 160 148 240
-152 -156 -158 -213 -221 -230 -251 -259 -272 -290 -303 -317
27 27 28 30 67 65 67 68 68 67 68 76

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?